Industry Insights

  1. The Rise Of Targeted Modalities In Pharmaceutical Development 8/11/2025

    Targeted modalities are pushing the boundaries of technology and therapeutic effectiveness. Their potential to transform patient care depends on leveraging the right expertise, technologies, and partnerships.

  2. Targeted Protein Degraders: Transforming Oral Therapeutics 8/11/2025

    CDMOs play a critical role in TPD development by offering specialized infrastructure and analytical capabilities to support the transition from preclinical research to clinical supply and commercialization.

  3. Targeted Modalities: Trends, Challenges, CDMO Considerations 8/11/2025

    Targeted modalities are designed to bind specifically to receptors or biological targets, ensuring a more directed and effective treatment while reducing systemic exposure and unintended side-effects.

  4. Future Predictions For Clinical Technologies 8/11/2025

    In 2025, sponsors are prioritizing configurable, interoperable solutions that integrate seamlessly across IRT, eCOA, CTMS, eConsent, and supply chain systems.

  5. A Guide To Electronic Data Capture (EDC) 8/11/2025

    EDC systems are designed to support a wide range of clinical research while ensuring compliance with global regulatory standards, revolutionizing data management in clinical trials.

  6. How To Improve Patient Outcomes Using eSource Software In Clinical Trials 8/11/2025

    As the demand for patient-centric clinical trials grows, eSource platforms will play an increasingly vital role in facilitating efficient, compliant, and innovative research methodologies.

  7. Running Global Clinical Trials? PolyPid Shares Operational And Regulatory Insights 8/11/2025

    PolyPid shares its clinical trial journey across the U.S., Europe, and Israel, highlighting operational complexities, regulatory navigation, and the adaptability required to execute large-scale, global studies. 

  8. AI In Clinical Trials: Key Insights From Industry Experts 8/8/2025

    Find out what experts from the FDA are saying about AI’s ability to demonstrably impact three critical success metrics in clinical trials.

  9. How Strategic LQPPV Outsourcing Future-Proofs PV Compliance In The AI Era 8/8/2025

    As health authorities seek standardization across global processes and strong AI governance, working with an experienced PV partner will help minimize the burden of oversight and ensure compliance.

  10. How Can Sponsors Enable Research-Naïve Clinical Trial Sites 8/8/2025

    Clinical trial capacity in the U.S. is heavily concentrated, and technology is playing a critical role in enabling a shift to expanding site networks and alleviating the burden on sites and patients.